China’s SIMM, French Drugmaker Servier To Collaborate On Anti-Tumor Medicine R&D

Shanghai Institute of Materia Medica (SIMM) and French pharmaceutical company Servier Laboratories signed an agreement on the R&D of targeted antitumor drug candidate lucitanib.